EGFR and non-small cell lung carcinoma: Overexpression or mutations of EGFR has been demonstrated in tumor cell formation and proliferation in some of human cancers such as liver, breast, stomach, colorectal cancers and particularly in glioblastoma and non-small cell lung carcinoma (NSCLC) [1–4].